Catalyst Pharmaceutical
CPRX
CPRX
164 hedge funds and large institutions have $446M invested in Catalyst Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 51 increasing their positions, 60 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.74% more ownership
Funds ownership: 63.28% → 64.02% (+0.74%)
15% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 60
Holders
164
Holding in Top 10
1
Calls
$261K
Puts
$6K
Top Buyers
| 1 | +$4.38M | |
| 2 | +$3.28M | |
| 3 | +$3.23M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.96M |
| 5 |
Renaissance Technologies
New York
|
+$2.51M |
Top Sellers
| 1 | -$8.18M | |
| 2 | -$6.89M | |
| 3 | -$3.07M | |
| 4 |
AC
Armistice Capital
New York
|
-$2.9M |
| 5 |
RA
Royce & Associates
New York
|
-$2.86M |